FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure Phase 3 data showed a 67% reduction in symptomatic infection among exposed household contacts who tested negative at baseline. By Kathryn Wighton June 2, 2026 3 min Conexiant Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions Top Thought Leaders
